DataMeds AI, Inc. (MEDS)
Nasdaq: MEDS · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Tampa, FL · filing with the SEC since 2024
Filings
147 filings since 2017 beside 32 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 49 days after the quarter ended. The proxy statement was last filed May 4, 2026.
Filings a yearinsider forms included
208970
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Oct 16, 2026.Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest May 21, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Nov 17, 2025.SEC letters: 25 in the last 36 months, the newest May 5, 2026.A late-filing notice, Form NT 10-Q, filed Aug 14, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-Q, filed Nov 14, 2025.A late-filing notice, Form NT 10-Q, filed Aug 14, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026
8-K items 1.02, 7.01, 9.01
Major agreement ended; Investor disclosure (Regulation FD) · Current report
Nov 3, 2026
Oct 26, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Oct 21, 2026
Oct 20, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Oct 19, 2026
Oct 16, 2026
8-K items 1.01, 3.01, 3.02
Major agreement signed; Listing warning from its exchange; Shares sold without registration · Current report
Oct 13, 2026
Sep 16, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Sep 11, 2026
Jul 21, 2026
8-K items 5.03, 8.01, 9.01
Charter, bylaw or fiscal-year change; Other event · Current report
Jul 20, 2026
Jun 12, 2026
8-K items 3.01, 8.01
Listing warning from its exchange; Other event · Current report
Jun 9, 2026
Jun 3, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
May 27, 2026
Jun 2, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
May 27, 2026
May 29, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
May 27, 2026
May 21, 2026
8-K items 1.01, 2.03, 3.02, 3.03, 5.02, 5.03, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Change to shareholders' rights; Officer or director change; Charter, bylaw or fiscal-year change · Current report
May 19, 2026
May 19, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
40 of 147 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.